Treatment of Infectious Gastroenteritis
The cornerstone of treatment for infectious gastroenteritis is oral rehydration therapy (ORT) with reduced osmolarity oral rehydration solution (ORS) as the first-line approach for mild to moderate dehydration in both children and adults. 1, 2
Assessment and Rehydration
- Evaluate hydration status through physical examination looking for specific signs including decreased skin turgor, dry mucous membranes, sunken eyes, altered mental status, tachycardia, and decreased urine output 1
- Categorize dehydration as:
- Mild: <4% body weight loss
- Moderate: 4-6% body weight loss
- Severe: >6% body weight loss 1
Rehydration Protocol
- For mild to moderate dehydration:
- Provide oral rehydration solution (ORS) as first-line therapy 2, 1
- Dosage: 50-100 mL/kg over 3-4 hours for infants and children; 2-4 L for adolescents and adults 1
- Use commercially available low-osmolarity ORS (e.g., Pedialyte, CeraLyte) 1, 3
- Avoid apple juice, sports drinks like Gatorade, and commercial soft drinks as primary rehydration solutions as they may have inappropriate electrolyte and sugar content 1
- For patients who cannot tolerate oral intake:
- For severe dehydration:
Nutritional Management
- Continue breastfeeding throughout the diarrheal episode in infants 1
- Resume age-appropriate diet during or immediately after rehydration 1
- Avoid fasting or withholding food for prolonged periods as this does not improve outcomes and may worsen nutritional status 2, 1
- Avoid foods high in simple sugars (soft drinks, undiluted apple juice, Jell-O, presweetened cereals) which can exacerbate diarrhea through osmotic effects 2
- Avoid foods high in fat as they may delay gastric emptying 2
Pharmacological Management
Antimicrobial Therapy
In immunocompetent children and adults, empiric antimicrobial therapy for infectious gastroenteritis is generally not recommended 2, 4
Exceptions where empiric antimicrobial therapy should be considered:
- Infants <3 months of age with suspected bacterial etiology 2
- Patients with fever documented in a medical setting, abdominal pain, bloody diarrhea, and bacillary dysentery presumptively due to Shigella 2
- Recent international travelers with fever ≥38.5°C and/or signs of sepsis 2
- Immunocompromised patients with severe illness and bloody diarrhea 2
- Patients with clinical features of sepsis who are suspected of having enteric fever 2
When antimicrobial therapy is indicated:
- For adults: fluoroquinolone (e.g., ciprofloxacin) or azithromycin, depending on local susceptibility patterns and travel history 2
- For children: third-generation cephalosporin for infants <3 months of age and others with neurologic involvement, or azithromycin 2
- Avoid antimicrobial therapy for STEC O157 and other STEC that produce Shiga toxin 2 as it may increase the risk of hemolytic uremic syndrome 2
Symptomatic Medications
Antiemetics:
Antimotility agents:
- Loperamide may be given to immunocompetent adults with acute watery diarrhea (4 mg initially, followed by 2 mg after each loose stool) 1
- Avoid antimotility agents in cases of bloody diarrhea, diarrhea with fever, or suspected toxic megacolon 2, 1
- Antiperistaltic drugs should be discontinued if symptoms persist beyond 48 hours 2
- Antimotility agents are not recommended for children 2
Special Populations
Immunocompromised Patients
- Consider empiric antibacterial treatment in immunocompromised people with severe illness and bloody diarrhea 2
- More aggressive diagnostic workup and treatment may be needed 2
Pregnant Women
- Pregnant women with Salmonella gastroenteritis should receive treatment to prevent extraintestinal spread 2
- Choices for treatment include ampicillin, cefotaxime, ceftriaxone, or TMP-SMZ 2
- Avoid fluoroquinolones during pregnancy 2
Prevention Measures
- Practice proper hand hygiene after using toilet, changing diapers, before/after food preparation, and after handling animals 1
- Use infection control measures including gloves, gowns, and hand hygiene with soap and water when caring for patients with diarrhea 1
- Asymptomatic contacts of people with bloody diarrhea should not be offered empiric treatment but should follow appropriate infection prevention measures 2
Follow-up
- Reassess fluid and electrolyte balance, nutritional status, and optimal dose and duration of antimicrobial therapy in people with persistent symptoms 2
- Consider noninfectious conditions, including inflammatory bowel disease and irritable bowel syndrome, in people with symptoms lasting 14 or more days 2